Nathalie Moll joined the European Federation of Pharmaceutical Industries and Associations (EFPIA) as Director General in April 2017.

EFPIA represents the pharmaceutical industry operating in Europe. Together with its direct membership 40 leading pharmaceutical companies, 33 national associations representing over 1,900 companies and in collaboration with health and research players, EFPIA’s mission is to create an environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.

Prior to joining EFPIA, between 2010 and 2017 Nathalie was the Secretary General of EuropaBio ranked as the most effective European Trade Association in Brussels in 2013. She spent over 20 years working for the biotech industry at EU and national level in associations and corporate positions and held the position of Chair and Vice Chair of the International Council of Biotech Associations (ICBA).

In 2013, Nathalie won the Technovisionaries Women Innovation Award organised by Women & Technologies® while in 2009, Nathalie and the Green Biotech Team of EuropaBio were presented with the Leadership and Excellence in Advancing Ag-Biotech and Food Issues Award. Nathalie was also named one of the 15 leading women in biotech in Europe in 2017.

Nathalie holds an Honours Degree in Biochemistry and Biotechnology from St Andrews University, Scotland.



Dr. Christina Rångemark Åkerman is Affiliate Faculty at the Dell Medical School at the University of Texas at Austin, Senior Institute Associate at the Institute for Strategy and Competitiveness (ISC) at Harvard Business School, Member of the Steering Committee of CHES (Coalition for Health, Ethics and Society) at the European Policy Center (EPC), an independent, not-for-profit think tank dedicated to fostering European integration through analysis and debate, and the Chair of The 5612 Group AB, which provides senior advice in the area of patient-centered, sustainable health and care.

Until August 2018, she was the President of the International Consortium for Health Outcomes Measurement (ICHOM), a non-profit organization with the purpose to transform health care systems worldwide by measuring and reporting patient outcomes in a standardized way. Between 2008 and 2014, she served as Director General for the Medical Products Agency (MPA) in Sweden, a national agency under the aegis of the Swedish Ministry of Health and Social Affairs. During this period, she was also a Member of the Board of the European Medicines Agency (EMA), which is responsible for the scientific evaluation of medicines for use in the European Union. Before her position with MPA, Christina served as Vice President Medical of AstraZeneca Sweden as well as Marketing Company President of AstraZeneca Philippines. She has also been working chair of start-up companies and on the Board of Fouriertransform, a Swedish state-owned venture capital company.

Christina received her medical degree from the University of Linköping. She wrote her doctoral thesis in Clinical Physiology and is a specialist in Clinical Pharmacology. She has an Executive MBA in General Management from the Stockholm School of Economics.



Associate professor Nils Wilking (NW) MD PhD has been active in clinical oncology for 40 years after graduating from the Karolinska Institutet in Stockholm, Sweden in 1977. NW has worked for many years in the field of surgical oncology, but has since the late 1980s mainly worked within medical oncology with a focus on breast and GI cancer. NW headed the Breast and GI Cancer Unit at the Karolinska hospital during 1992-1998. During this period, he also set up and headed the clinical trial unit at the Department of Oncology. In 1998, NW joined Eli Lilly as a senior research physician. In 2001, he moved to BMS where he held a European position in their oncology team. Since 2003, he has worked in a research context linked to the Karolinska Institutet.

2010-17, NW served as Senior Strategic Advisor for the Southern Health Care Region in Sweden. 2012-2016, NW was also head of the Oncology department at Skåne University hospital in Lund (the largest cancer clinic in Sweden).

NWs main focus has been on research in relation to health service delivery.

NW has published a number of reports in the cancer area: http://www.comparatorreports.se/

 Most recent report in 2019: https://ihe.se/publicering/comparator-report-on-cancer-in-europe-2019-2/



Marius Geantă is President and Co-Founder of the Center for Innovation in Medicine, a non governmental organisation based in Bucharest, Romania, focused on innovation in the healthcare sector. The aim of the Center for Innovation in Medicine is to shorten the time between the emergence of innovations in the medical sector and their application so that they can benefit patients both in Romania and elsewhere.

In the context of Romanian Presidency of EU Council 2019, The Center for Innovation in Medicine proposed the vision paper “A new vision for cancer in Europe: data, technology and human touch” to be included in the EU Beating Cancer Plan.

Marius is a pioneer in the field of personalised medicine in Romania and Central Eastern Europe and is involved in some pan-European innovative healthcare projects, such as Information Technology: The Future of Cancer Treatment, DigiTwins Consortium, International Consortium for PersonalisedMedicine, Public Health Genomics Network, PECAN, Building Blocks for Personalised Medicine.

As President of the Centre for Innovation in Medicine, Marius is the coordinator of “State of Innovation in Medicine” Annual Report and the organiser of the high-level events Science meets Politicians (in partnership with Romanian Parliament) and Personalised Medicine Conference (two editions in partnership with Romanian Presidential Administration).



Matti Aapro is member of the Board of Directors of the Genolier Cancer Center, Genolier, Switzerland and President (2020-2021) of ECCO (European CanCer Organisation).

He received his medical degree from the Faculty of Medicine, University of Geneva, Switzerland and was a fellow at the Arizona Cancer Center in Tucson, Arizona, USA. He was the founding chair of the Medical and Radiation Therapy Department at the European Institute of Oncology in Milan. Dr. Aapro collaborates with the European School of Oncology (ESO), coordinating the activities of ESO in Arab speaking countries and in Latin America. He is President of the Sharing Progress in Cancer Care (SPCC) not-for-profit association. He serves the International Society for Geriatric Oncology (SIOG) as Executive Board Member. He is past-President of the Multinational Association for Supportive Care in Cancer (MASCC). He is President of Honour of the French-speaking Society for Supportive Care (AFSOS), as well as Advisor to the Japanese Association for Supportive Care in Cancer (JASCC). He has been member of the Board of the European Organization for Research and Treatment of Cancer (EORTC) and of the Board of the European Society of Medical Oncology (ESMO).

Dr. Aapro chaired the scientific and organizing committees of UICC’s (International Union against Cancer) World Cancer Congress of 2008 in Geneva, and 2010 in Shenzhen (China). He is a member of the ESMO Faculty and chaired the ESMO 2018 Supportive/Palliative Care track. Dr. Aapro is Honorary Editor of Critical Reviews in Oncology/Hematology, and editor of the Journal of Cancer Policy as well as Associate Editor for the geriatric section of the Oncologist. He is also founding editor of the Journal of Geriatric Oncology. He is past Associate Editor for Annals of Oncology, continuing on its editorial board, and member of several other editorial boards including the magazine CancerWorld. He has authored more than 350 publications and his major interests are new drug development, breast cancer, cancer in the elderly, and supportive care.

Dr. Aapro is Doctor Honoris Causa of the University of Tampere (2013) and Honorary Member of the Russian Society for Clinical Oncology (RUSSCO)(2016). He has received the 2010 Acta Oncologica Award, the 2012 ASCO B.J. Kennedy prize and the MASCC Distinguished Services Award (2016).



Eduard Vrdoljak is Professor and Head of the Oncology Centre at the Clinical Hospital in Split, Croatia and, at present, visiting Professor at the Medical School in Mostar, Bosnia and Herzegovina and visiting Professor at University of Skopje Faculty of Medicine, Republic of Macedonia.

Professor Vrdoljak obtained his diploma from the University of Zagreb, Croatia in 1989. After obtaining a medical degree, he continued his training at the University of Texas, MD Anderson Cancer Center, TX, USA. In 1995, he obtained his PhD in oncology and finished his residency in oncology and radiotherapy.

Prof. Vrdoljak is currently Head of the Croatian Cooperative Group for Clinical Research in Oncology (CCGCRO), the South-Eastern European Research Oncology Group (SEEROG) and the Croatian Society of Oncology. He is a member of several cancer-related associations where he served at different levels such as member of the International Affairs Committee of the American Society of Clinical Oncology. He is an active member working as the faculty of the European School of Oncology.

Prof. Vrdoljak was awarded the 10th International Congress of Radiation Research Young Scientist Young Travel Award 1995, the World Association of Croatian Physicians Fellowship Award in 1995, the Croatian Science and Art Academy Award for the best scientist in 2008, the Town of Split’s personal award in 2008 and Science national award in 2014.

During his professional career, Prof. Vrdoljak has authored numerous publications in peer-reviewed journals, and is the author or co-author of many oncology-related books.



Antonella Cardone is the Director of the European Cancer Patient Coalition, which is the largest cancer patient umbrella organization in Europe with over 450 members from 49 countries. She has over twenty years of international activity in health, social and employment sectors.

Prior to ECPC, Antonella was the Executive Director of the Fit for Work Global Alliance, a multi-stakeholder coalitionchampioning change in health and work policy. She was previously Director of the Global Smokefree Partnership of the American Cancer Society, leading a movement of over 100 members to coordinate the development of smokefree laws in 40 countries.

She holds a Master’s in Science and one in Business Administration. She currently represents ECPC on the Board of Pancreatic Cancer Europe



Croatian Minister of Health, Vili Beroš, is a specialized neurosurgeon who obtained his diploma from the University of Zagreb, School of Medicine in 1989 and his PhD in postgraduate doctoral studies at the Faculty of Science, University of Zagreb in the field of molecular biology in 2006.

Since 2012 he is also Associate Professor in the field of biomedical sciences at the Faculty of Education and Rehabilitation Sciences, University of Zagreb. Field: clinical medical sciences / surgery.

During his professional career, Minister Beroš was author and co-author of numerous scientific publications. More details on his career can be found at https://zdravlje.gov.hr/o-ministarstvu/ustrojstvo/ministar-2913/2913

SINIŠA VARGAConference moderator


Conference moderator

Member of Croatian Parliament, former Minister of Health

Dr. Varga has more than 27 years of relevant professional work experience as provider of health services and senior manager in a tertiary care hospital; payer of health services as director of the National Health Insurance Fund; policy maker as minister of health and deputy minister of health; and as an international consultant for healthcare reforms in close communication with international organizations, government institutions, and non-governmental organizations.

Dr. Varga also has more than 13 years of work experience in healthcare restructuring activities including designing and executing the National (master) Plan for the Development of Hospitals in the Republic of Croatia from 2014 to 2016; reform of health organization payment systems includin the introduction of KPIs and QIs linked to outcomes; realigning the role of family medicine centers; emergency medicine reforms; and health institution financial rehabilitation.

He has extensive knowledge and experience as a senior and lead consultant involved in reforms for numerous projects in Western Europe, Central or Eastern Europe, and especially in the Western Balkan countries.